Skip to main content

Polyene Antibiotics in Experimental Transmissible Subacute Spongiform Encephalopathies

  • Chapter

Part of the book series: NATO ASI Series ((NSSA,volume 295))

Abstract

Transmissible subacute spongiform encephalopathies (TSSE) form a group of fatal neurodegenerative diseases which include Creutzfeldt-Jakob disease in humans, scrapie in sheep and goats and bovine spongiform encephalopathy (BSE) in cattle. They are characterized by a long incubation period which precedes clinical symptoms related to the central nervous system (CNS) degeneration. In experimental models, a modified proteinase-resistant form (PrPres) of a host-encoded protein (PrP) accumulates in the brain proportionally to infectivity1,2. A transcriptional overexpression of glial fibrillary acidic protein (GFAP), a specific marker of astrocytes, has also been observed3,4,5.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. S. B. Prusiner, Novel proteinaceous infectious particles cause scrapie, Science. 216: 136 (1982).

    Article  PubMed  CAS  Google Scholar 

  2. D. C. Bolton, M. P. McKinley, and S. B. Prusiner, Identification of a protein that purifies with the scrapie prion, Science. 218: 1309 (1982).

    Article  PubMed  CAS  Google Scholar 

  3. D. Dormont, B. Delpech, A. Delpech, M. N. Courcel, J. Viret, P. Markovits, and L. Court, Hyperproduction de protéine gliofibrillaire acide (GFAP) au cours de l’évolution de la tremblante expérimentale de la souris, C R Acad Sc Paris. 293: 53 (1981).

    CAS  Google Scholar 

  4. F. Lazarini, J. P. Deslys, and D. Dormont, Variations in prion protein and glial fibrillary acidic protein messenger RNAs in the brain of scrapie-infected newborn mouse, J Gen Virol. 73: 1645 (1992).

    Article  PubMed  CAS  Google Scholar 

  5. A. Mackenzie, Immunohistochemical demonstration of glial fibrillary acidic protein in scrapie, J Comp Pathol. 93: 251 (1983).

    Article  PubMed  CAS  Google Scholar 

  6. P. Brown, A therapeutic panorama of the spongiform encaphalopathies, Antiviral Chemistry & Chemoth. 1: 75 (1990).

    Google Scholar 

  7. R. H. Kimberlin, and C. A. Walker, The antiviral compound HPA-23 can prevent scrapie when administred at the time of infection, Arch Virol 78: 9 (1983).

    Article  PubMed  CAS  Google Scholar 

  8. R. H. Kimberlin, and C. A. Walker, Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions, Antimicrob Agents Chemother. 30: 409 (1986).

    Article  PubMed  CAS  Google Scholar 

  9. L. Ingrosso, A. Ladogana, and M. Pocchiari, Congo red prolongs the incubation period in scrapie-infected hamsters, J Virol. 69: 506 (1995).

    PubMed  CAS  Google Scholar 

  10. H. Amyx, A. M. Salazar, D. C. Gajdusek, and C. J. Gibbs, Chemotherapeutic trials in experimental slow virus disease, Neurology. 34: 149 (1984).

    Google Scholar 

  11. M. Pocchiari, S. Schmittinger, A. Ladogana, and C. Masullo, Effects of Amphotericin B in intracerebrally scrapie inoculated hamster, in Unconventional Virus Diseases of the Central Nervous System, L.A. Court, D. Dormont, P. Brown and D.T. Kingsbury, eds., C.E.A. diffusion, Paris (1986).

    Google Scholar 

  12. M. Pocchiari, S. Schmittinger, and C. Masullo, Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters, J Gen Virol. 68: 219 (1987).

    Article  PubMed  CAS  Google Scholar 

  13. M. Pocchiari, P. Casaccia, and A. Ladogana, Amphotericin B: a novel class of antiscrapie drugs, J Infect Dis. 160: 795 (1989).

    Article  PubMed  CAS  Google Scholar 

  14. R. T. Proffitt, A. Satorius, S. M. Chiang, L. Sullivan, and J. P. Adler-Moore, Pharmacology and toxicology of a liposomal formulation of amphotericin B (Ambisome) in rodents, J Antimicrob Chemother. 28, Suppl. B: 49 (1991).

    Article  PubMed  CAS  Google Scholar 

  15. E. S. Tabosa Do Egito, M. Appel, H. Fessi, G. Barratt, F. Puisieux, and J. P. Devissaguet, in-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system, J Antimicrob Chemother. 38: 485 (1996).

    Article  PubMed  CAS  Google Scholar 

  16. Y. G. Xi, L. Ingrosso, A. Ladogana, C. Masullo, and M. Pocchiari, Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation, Nature. 356: 598 (1992).

    Article  PubMed  CAS  Google Scholar 

  17. D. McKenzie, J. Kaczkowski, R, Marsh, and J. Aiken, Amphotericin B delays scrapie agent replication and PrP-res accumulation early in infection, J Virol. 68: 7534 (1994).

    PubMed  CAS  Google Scholar 

  18. M. Magierowskajung, D. Cefai, H. Marrakchi, F. Chieze, H. Agut, J. M. Huraux, and M. Seman, In vitro determination of antiviral activity of MS-8209, a new amphotericin B derivative, against primary isolates of HIV 1, Res Virol. 147: 313 (1996).

    Article  CAS  Google Scholar 

  19. O. Pleskoff, N. Sol, H. Marrakchi, M. Serlin, M. Seman, and M. Alizon, Possible role of the V3 domain of gp 120 in resistance to an Amphotericin B derivative (MS-8209) blocking human immunodefiency virus entry, J Virol 70: 8247 (1996).

    PubMed  CAS  Google Scholar 

  20. L. Saint-Julien, V. Joly, M. Seman, C. Carbon, and P. Yeni, Activity of MS-8209, a nonester Amphotericin B derivative, in treatment of experimental systemic mycoses, Antimicrob Agents Chemother. 36:2722 (1992).

    Article  PubMed  CAS  Google Scholar 

  21. C. I. Lasmézas, J. P. Deslys, R. Demaimay, K. T. Adjou, J. J. Hauw, and D. Dormont, Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy, J Gen Virol 77:1601 (1996).

    Article  PubMed  Google Scholar 

  22. C. I. Lasmézas, J. P. Deslys, O. Robain, A. Jaegly, V. Beringue, J. M. Peyrin, J. G. Fournier, J. J. Hauw, J. Rossier, and D. Dormont, Transmission of BSE agent to mice in the absence of detectable abnormal prion protein, Science. 275:402 (1997).

    Article  PubMed  Google Scholar 

  23. L. J. Reed, and H. Muench, A simple method of estimating fifty percent endpoints, Amer J Hygiene. 27:493 (1938).

    Google Scholar 

  24. S. B. Prusiner, S. P. Cochran, D. F. Groth, D. E. Downey, K. A. Bowman, and H. M. Martinez, Measurement of the scrapie agent using an incubation time interval assay, Ann Neurol. 11:353 (1982).

    Article  PubMed  CAS  Google Scholar 

  25. K. T. Adjou, R. Demaimay, C. I. Lasmézas, J. P. Deslys, M. Seman, and D. Dormont, MS-8209, a new amphotericin B derivative, provides enhanced efficacy in delaying hamster scrapie, Antimicrob Agents Chemother. 39:2810 (1995).

    Article  PubMed  CAS  Google Scholar 

  26. R. Demaimay, K. T. Adjou, V. Beringue, S. Demart, F. Lamoury, C. I. Lasmézas, J. P. Deslys, M. Seman, and D. Dormont, Polyene antibiotics in experimental transmissible spongiform encephalopathies, in Transmissible Subacute Spongiform Encephalopathies: Prion Diseases, L. Court and B. Dodet, eds., Elsevier, Paris (1996).

    Google Scholar 

  27. R. Demaimay, K. T. Adjou, C. I. Lasmézas, F. Lazarini, K. Cherifi, M. Seman, J. P. Deslys, and D. Dormont, Pharmalogical studies of a new derivative of Amphotericin B, MS-8209, in mouse and hamster scrapie, J Gen Virol 75, 2499 (1994).

    Article  PubMed  CAS  Google Scholar 

  28. K. T. Adjou, R. Demaimay, C. I. Lasmézas, M. Seman, J. P. Deslys, and D. Dormont, Differential effects of a new Amphotericin B derivative, MS-8209, on mouse BSE and scrapie: Implications for the mechanism of action of polyene antibiotics, Res Virol. 147:213 (1996).

    Article  PubMed  CAS  Google Scholar 

  29. R. I. Carp, Scrapie, unconventional infectious agent, in Neuropathogenic Viruses and Immunity, S. Specter, ed., Plenum Press, New-York (1992).

    Google Scholar 

  30. M. Pocchiari, L. Ingrosso, and A. Ladogana, Effect of Amphotericin B on different experimental strains of spongiform encephalopathy agents, in Bovine Spongiform Encephalopathy: the BSE Dilemma, C. J. Gibbs Jr, ed., Springer Verlag, New-york (1996).

    Google Scholar 

  31. K. T. Adjou, J. P. Deslys, R. Demaimay, and D. Dormont, Probing the dynamics of prion diseases with Amphotericin B, Trends Microb. 5:27 (1997).

    Article  CAS  Google Scholar 

  32. R. H. Kimberlin, and C. A. Walker, Pathogenesis of mouse scrapie: effect of route of inoculation on infectivity titres and dose-response curves, J Comp Pathol. 88:39 (1978).

    Article  PubMed  CAS  Google Scholar 

  33. R. H. Kimberlin, and C. A. Walker, Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes, J Comp Pathol. 89:551 (1979).

    Article  PubMed  CAS  Google Scholar 

  34. R. H. Kimberlin, and C. A. Walker, Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly, J Gen Virol. 67:255 (1986b).

    Article  PubMed  Google Scholar 

  35. H. Diringer, and B. Ehlers, Chemoprophylaxis of scrapie in mice, J Gen Virol. 72:457 (1991).

    Article  PubMed  CAS  Google Scholar 

  36. B. Ehlers, and H. Diringer, Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen, J Gen Virol. 65:1325 (1984).

    Article  PubMed  CAS  Google Scholar 

  37. A. Ladogana, P. Casaccia, L. Ingrosso, M. Cibati, M. Salvatore, Y. G. Xi, C. Masullo, and M. Pocchiari, Sulphate polyanions prolong the incubation period of scrapie-infected hamsters, J Gen Virol. 73:661 (1992).

    Article  PubMed  CAS  Google Scholar 

  38. H. A. Gallis, R. H. Drew, and W. W. Pickard, Amphotericin B: 30 years of clinical experience, Reviews of Infectious Diseases. 12:308 (1990).

    Article  PubMed  CAS  Google Scholar 

  39. Y. L. Chung, A. Williams, J. S. Beech, S. C. R. Williams, J. D. Bell, J. Cox, and J. Hope, MRI assessment of the blood-brain barrier in a hamster model of scrapie, Neurodegeneration. 4:203 (1995).

    Article  PubMed  CAS  Google Scholar 

  40. F. C. Szoka, and M. Tang, Amphotericin B formulated in liposomes and lipid based systems: a review, J Liposome Res. 3:363 (1993).

    Article  CAS  Google Scholar 

  41. A. Vertut-Doï, S. I. Ohnishi, and J. Bolard, The endocytic process in CHO cells, a toxic pathway of the polyene antibiotic Amphotericin B, Antimicrob Agents Chemother. 38:2373 (1994).

    Article  PubMed  Google Scholar 

  42. B. Chesebro, and B. Caughey, Scrapie agent replication without the prion protein, Curr Biol. 3:696 (1993).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Beringue, V. et al. (1998). Polyene Antibiotics in Experimental Transmissible Subacute Spongiform Encephalopathies. In: Morrison, D.R.O. (eds) Prions and Brain Diseases in Animals and Humans. NATO ASI Series, vol 295. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1896-3_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-1896-3_18

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-1898-7

  • Online ISBN: 978-1-4899-1896-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics